NCT04806594View on ClinicalTrials.gov

Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar.

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 25, 2020

Primary Completion Date

July 1, 2021

Study Completion Date

July 1, 2021

Conditions
AcneScars
Interventions
DEVICE

Papix acne scar

PapiX acne scar, class IIa medical device, gel for acne scar. to be applied 2 times per day during the 8 weeks of study duration

Trial Locations (1)

16132

Ospedale San Martino, Genova

All Listed Sponsors
lead

Relife S.r.l.

INDUSTRY

NCT04806594 - Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar. | Biotech Hunter | Biotech Hunter